Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Atrys Health SA ( (ES:ATRY) ) has shared an announcement.
Atrys Health SA has announced a leadership succession plan, with Marian Isach set to become the new CEO, replacing Isabel Lozano, who will transition to a non-executive director role. Santiago de Torres will shift from executive to non-executive chairman. This move is part of a broader generational change strategy initiated in 2024, aimed at promoting internal talent and ensuring continuity in the company’s leadership model. The company also reported an 11.2% revenue increase in the first quarter of 2025, driven by growth across all business areas, particularly in Oncology and Diagnosis, highlighting Atrys’ ongoing expansion and market strength.
More about Atrys Health SA
Atrys is a global healthtech company specializing in prevention, diagnosis, and precision treatment services, with a strong presence in telemedicine and cancer treatment. It has established itself as a leader in the Spanish-speaking telemedicine market and is a pioneer in high-precision oncological radiotherapy in Europe.
Average Trading Volume: 47,520
Technical Sentiment Signal: Strong Sell
Current Market Cap: €218.1M
Learn more about ATRY stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue